flumazenil has been researched along with Agammaglobulinemia in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Agammaglobulinemia: An immunologic deficiency state characterized by an extremely low level of generally all classes of gamma-globulin in the blood.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baffelli, R | 1 |
Notarangelo, LD | 1 |
Imberti, L | 1 |
Hershfield, MS | 1 |
Serana, F | 1 |
Santisteban, I | 1 |
Bolda, F | 1 |
Porta, F | 1 |
Lanfranchi, A | 1 |
1 other study available for flumazenil and Agammaglobulinemia
Article | Year |
---|---|
Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.
Topics: Adenosine Deaminase; Agammaglobulinemia; Child, Preschool; Consanguinity; DNA Mutational Analysis; E | 2015 |